WDR3: Potential Drug Target and Regulator of Tissue Repair and Plasticity

WDR3: Potential Drug Target and Regulator of Tissue Repair and Plasticity

WDR3 (Wnt-driven receptor 3) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the Wnt signaling pathway, a well-established pathway that plays a crucial role in the development and maintenance of tissues and organs during embryonic development and throughout life.

WDR3 has been identified as a potential drug target and has been shown to be involved in a variety of physiological processes, including tissue repair, regeneration, and plasticity. Its function in these processes has been attributed to its role in the regulation of cell proliferation, differentiation, and survival.

One of the key functions of WDR3 is its role in tissue repair and regeneration. WDR3 has been shown to be involved in the regulation of cell proliferation and differentiation, as well as in the formation of new tissues during wound healing and regeneration. For example, studies have shown that WDR3 is involved in the regulation of the proliferation of stem cells, and that it plays a role in the development of new tissues after injury or disease.

Another function of WDR3 is its role in plasticity, which refers to the ability of cells and tissues to change and adapt in response to various stimuli. WDR3 has been shown to be involved in the regulation of cell plasticity, and has been shown to play a role in the development of new tissues and organs during development and regeneration.

In addition to its role in tissue repair and plasticity, WDR3 is also involved in the regulation of cell survival and has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached a certain level of dysfunction or when they are no longer needed.

WDR3 has also been shown to be involved in the regulation of various signaling pathways, including the Wnt signaling pathway, the TGF-β signaling pathway, and the PI3K/AKT signaling pathway. These signaling pathways are involved in a variety of cellular processes, including cell proliferation, differentiation, and survival, and are important for the development and maintenance of tissues and organs during embryonic development and throughout life.

Given its involvement in a variety of physiological processes, WDR3 has been identified as a potential drug target. Studies have shown that inhibiting the activity of WDR3 has the potential to treat a variety of diseases and conditions, including cancer, neurodegenerative diseases, and developmental disorders. In addition, WDR3 has also been shown to be involved in the regulation of various biomarkers, such as the Wnt signaling pathway, which has the potential to serve as a biomarker for a variety of diseases.

In conclusion, WDR3 is a protein that is involved in a variety of physiological processes and has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. Its potential as a drug target makes it an attractive target for the development of new therapies for a variety of diseases and conditions. Further research is needed to fully understand the role of WDR3 in various physiological processes and to develop effective treatments based on its properties.

Protein Name: WD Repeat Domain 3

Functions: Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome

The "WDR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6